Merck KGaA continues expansion with $285M+ investment in 2 new projects in France and Germany
It is no secret that Merck KGaA has been on an expansion drive across the US and Ireland over the past year, but its latest move will look to boost the company’s presence in mainland Europe too.
The company is looking to invest around €130 million ($129 million) into single-use assemblies as part of the production of Covid-19 vaccines and other therapeutics at its site in Molsheim, France, a city in the east of the country. The investment in the 50-year-old site will also aim to create around 800 jobs by 2028.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.